Hasil Pencarian - Michael A.S. Jewett

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment

    Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment oleh Lei Zhang, Lin Yao, Xuesong Li, Michael A.S. Jewett, Zhisong He, Liqun Zhou

    Diterbitkan 2016-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer

    A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer oleh Girish S. Kulkarni, Lothar Lilge, Michael Nesbitt, Roger J. Dumoulin-White, Arkady Mandel, Michael A.S. Jewett

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Evidence of Chromosomal Instability in Prostate Cancer Determined by Spectral Karyotyping (SKY) and Interphase FISH Analysis

    Evidence of Chromosomal Instability in Prostate Cancer Determined by Spectral Karyotyping (SKY) and Interphase FISH Analysis oleh Ben Beheshti, Paul C. Park, Joan M. Sweet, John Trachtenberg, Michael A.S. Jewett, Jeremy A. Squire

    Diterbitkan 2001-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Optimal management of high-risk T1G3 bladder cancer: a decision analysis.

    Optimal management of high-risk T1G3 bladder cancer: a decision analysis. oleh Girish S Kulkarni, Antonio Finelli, Neil E Fleshner, Michael A S Jewett, Steven R Lopushinsky, Shabbir M H Alibhai

    Diterbitkan 2007-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Required efficacy for novel therapies in BCG‐unresponsive non‐muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?

    Required efficacy for novel therapies in BCG‐unresponsive non‐muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes? oleh Marian S. Wettstein, David Naimark, Thomas Hermanns, Jaime O. Herrera‐Caceres, Ardalan Ahmad, Michael A.S. Jewett, Girish S. Kulkarni

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: